본문 바로가기
KERD
논문KCI 등재

Parenteral Nutrition-Associated Cholestasis in Very Low Birth Weight Infants: A Single Center Experience

1

조회

0

다운로드

1

인용

0

참고문헌

키워드

주제분류소아과학

초록

Purpose: Parenteral nutrition (PN)-associated cholestasis (PNAC) is one of the most common complications in very low birth weight infants (VLBWIs). The aim of this study is to evaluate the risk factors of PNAC in VBLWIs.Methods: We retrospectively reviewed the medical records of 322 VLBWIs admitted to the neonatal intensive care unit of our hospital from July 1, 2009 to December 31, 2013. We excluded 72 dead infants; 6 infants were transferred to another hospital, and 57 infants were transferred to our hospital at 2 weeks after birth. The infants were divided into the cholestasis and the non-cholestasis groups. PNAC was defined as a direct bilirubin level of ≥2.0 mg/dL in infants administered with PN for ≥2 weeks.Results: A total of 187 VLBWI were enrolled in this study; of these, 46 infants developed PNAC. Multivariate logistic regression analysis showed that the risk factors of PNAC in VLBWI were longer duration of antimicrobial use (odds ratio [OR] 4.49, 95% confidence interval [95% CI] 4.42-4.58), longer duration of PN (OR 2.68, 95% CI 2.41-3.00), long-term lack of enteral nutrition (OR 2.89, 95% CI 2.43-3.37), occurrence of necrotizing enterocolitis (OR 2.40, 95% CI 2.16-2.83), and gastrointestinal operation (OR 2.19, 95% CI 2.03-2.58).Conclusion: The results of this study suggest that shorter PN, aggressive enteral nutrition, and appropriate anti-microbial use are important strategies in preventing PNAC.

Abstract

Purpose: Parenteral nutrition (PN)-associated cholestasis (PNAC) is one of the most common complications in very low birth weight infants (VLBWIs). The aim of this study is to evaluate the risk factors of PNAC in VBLWIs.Methods: We retrospectively reviewed the medical records of 322 VLBWIs admitted to the neonatal intensive care unit of our hospital from July 1, 2009 to December 31, 2013. We excluded 72 dead infants; 6 infants were transferred to another hospital, and 57 infants were transferred to our hospital at 2 weeks after birth. The infants were divided into the cholestasis and the non-cholestasis groups. PNAC was defined as a direct bilirubin level of ≥2.0 mg/dL in infants administered with PN for ≥2 weeks.Results: A total of 187 VLBWI were enrolled in this study; of these, 46 infants developed PNAC. Multivariate logistic regression analysis showed that the risk factors of PNAC in VLBWI were longer duration of antimicrobial use (odds ratio [OR] 4.49, 95% confidence interval [95% CI] 4.42-4.58), longer duration of PN (OR 2.68, 95% CI 2.41-3.00), long-term lack of enteral nutrition (OR 2.89, 95% CI 2.43-3.37), occurrence of necrotizing enterocolitis (OR 2.40, 95% CI 2.16-2.83), and gastrointestinal operation (OR 2.19, 95% CI 2.03-2.58).Conclusion: The results of this study suggest that shorter PN, aggressive enteral nutrition, and appropriate anti-microbial use are important strategies in preventing PNAC.

참고문헌 (30)

  1. Jolin-Dahel K, "Parenteral nutrition- induced cholestasis in neonates: where does the problem lie", Gastroenterol Res Pract, 2013, pp.163632~ (2013)
  2. Hsieh MH, "Parenteral nutrition-associated cholestasis in premature babies: risk factors and predictors", Pediatr Neonatol, 50, pp.202~207 (2009)
  3. McKiernan PJ, "Neonatal cholestasis", Semin Neonatol, 7, pp.153~165 (2002)
  4. Hofmann AF, "Defective biliary secretion during total parenteral nutrition: probable mechanisms and possible solutions", J Pediatr Gastroenterol Nutr, 20, pp.376~390 (1995)
  5. Chen CY, "The risk factors of parenteral nutrition- associated cholestasis in preterm infants", Pediatr Neonatol, 50, pp.181~183 (2009)
  6. 최진성, "총정맥영양 연관 담즙정체증", Korean Journal of Pediatrics, 49(9), pp.972~976 (2006), 대한소아과학회
  7. Whitington PF, "Cholestasis associated with total parenteral nutrition in infants", Hepatology, 5, pp.693~696 (1985)
  8. Cheung HM, "Rescue treatment of infants with intestinal failure and parenteral nutrition-associated cholestasis (PNAC) using a parenteral fish-oil-based lipid", Clin Nutr, 28, pp.209~212 (2009)
  9. Brown SJ, "Hepatotoxicity of antimicrobial agents", Semin Liver Dis, 22, pp.157~167 (2002)
  10. Kullak-Ublick GA, "Hepatic transport of bile salts", Semin Liver Dis, 20, pp.273~292 (2000)
  11. 윤수정, "신생아에서 패혈증 연관성 담즙정체증의 임상 양상", Korean Journal of Pediatrics, 47(4), pp.380~385 (2004), 대한소아과학회
  12. Vargas V, "Listeria monocytogenes-associated acute hepatitis in a liver transplant recipient", Liver, 18, pp.213~215 (1998)
  13. Goulet OJ, "Intestinal failure-associated liver disease and the use of fish oil-based lipid emulsions", World Rev Nutr Diet, 112, pp.90~114 (2015)
  14. Aghai ZH, "Fluconazole prophylaxis in extremely low birth weight infants: association with cholestasis", J Perinatol, 26, pp.550~555 (2006)
  15. Kaufman DA, "Fluconazole prophylaxis in preterm infants: a multicenter case-controlled analysis of efficacy and safety", Early Hum Dev, 90(Suppl 1), pp.S87~S90 (2014)
  16. Drongowski RA, "An analysis of factors contributing to the development of total parenteral nutrition- induced cholestasis", JPEN J Parenter Enteral Nutr, 13, pp.586~589 (1989)
  17. Christensen RD, "Identifying patients, on the first day of life, at high-risk of developing parenteral nutrition- associated liver disease", J Perinatol, 27, pp.284~290 (2007)
  18. Kim H, "Total parenteral nutrition-associated cholestasis in very low birth weight infants", J Korean Soc Neonatol, 8, pp.200~205 (2001)
  19. Jeon GW, "The risk factors of cholestasis in very low birth weight infants", J Korean Soc Neonatol, 12, pp.63~69 (2005)
  20. Bolisetty S, "Australasian Neonatal Parenteral Nutrition Consensus Group. Standardised neonatal parenteral nutrition formulations - an Australasian group consensus 2012", BMC Pediatr, 14, pp.48~ (2014)
  21. Messing B, "Chronic cholestasis and macronutrient excess in patients treated with prolonged parenteral nutrition", Nutrition, 8, pp.30~36 (1992)
  22. Lloyd DA, "Chronic biochemical cholestasis in patients receiving home parenteral nutrition: prevalence and predisposing factors", Aliment Pharmacol Ther, 27, pp.552~560 (2008)
  23. Vileisis RA, "Prospective controlled study of parenteral nutrition-associated cholestatic jaundice: effect of protein intake", J Pediatr, 96, pp.893~897 (1980)
  24. 강성진, "미숙아에서 정맥 영양 내 아미노산 공급량의 변화가 간기능에 미치는 영향", Perinatology, 21(3), pp.266~272 (2010), 대한주산의학회
  25. Dorvil NP, "Taurine prevents cholestasis induced by lithocholic acid sulfate in guinea pigs", Am J Clin Nutr, 37, pp.221~232 (1983)
  26. Moran JM, "Taurine and cholestasis associated to TPN. Experimental study in rabbit model", Pediatr Surg Int, 21, pp.786~792 (2005)
  27. Lee HY, "The effect of early enteral trophic feeding within 24 hours after birth in extremely low birth weight infants of 26 weeks and less, and birth weight below 1,000 g", J Korean Soc Neonatol, 14, pp.59~65 (2007)
  28. Loomis T, "Impact of standardized feeding guidelines on enteral nutrition administration, growth outcomes, metabolic bone disease, and cholestasis in the NICU", J Pediatr Gastroenterol Nutr, 59, pp.93~98 (2014)
  29. 박경필, "미숙아에서의 전비경구적 영양 관련 답즙울체", Korean Journal of Pediatrics, 46(1), pp.17~23 (2003), 대한소아과학회
  30. Veenstra M, "Enteral nutrition and total parenteral nutrition components in the course of total parenteral nutrition-associated cholestasis in neonatal necrotizing enterocolitis", Surgery, 156, pp.578~583 (2014)

관련 논문AI추천

이 간행물의 다른 논문 (9건)